| |
| |
|
| Insider
Information: |
Thomsen Jillian B. |
| Relationship: |
Chief Financial Officer |
| City: |
San Carlos |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
313,497 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$398,141 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
313,497 |
|
|
| Total
Value |
$398,141 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -548.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
Chief Financial Officer |
2023-02-16 |
313,497 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2017-03-20 |
4 |
AS |
$19.69 |
$2,215,125 |
D/D |
(112,500) |
55,637 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2016-07-11 |
4 |
AS |
$15.09 |
$1,509,000 |
D/D |
(100,000) |
6,809 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2018-04-16 |
4 |
AS |
$101.46 |
$1,408,366 |
D/D |
(13,881) |
68,857 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2021-01-28 |
4 |
AS |
$18.62 |
$1,396,500 |
D/D |
(75,000) |
176,257 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2017-03-20 |
4 |
OE |
$7.21 |
$1,120,875 |
D/D |
112,500 |
168,137 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2020-02-06 |
4 |
AS |
$22.78 |
$854,250 |
D/D |
(37,500) |
175,480 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2019-02-04 |
4 |
AS |
$42.16 |
$679,577 |
D/D |
(16,119) |
168,199 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2021-01-28 |
4 |
OE |
$8.80 |
$660,000 |
D/D |
75,000 |
251,257 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2016-07-11 |
4 |
OE |
$4.65 |
$465,000 |
D/D |
100,000 |
106,809 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2018-05-16 |
4 |
S |
$83.39 |
$298,203 |
D/D |
(3,576) |
65,281 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2018-08-16 |
4 |
D |
$58.40 |
$285,167 |
D/D |
(4,883) |
71,265 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2020-02-06 |
4 |
OE |
$7.21 |
$270,375 |
D/D |
37,500 |
212,980 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2021-02-16 |
4 |
S |
$22.37 |
$261,841 |
D/D |
(11,705) |
164,552 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2021-05-17 |
4 |
S |
$18.30 |
$245,055 |
D/D |
(13,391) |
151,161 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2015-12-03 |
4 |
AS |
$15.87 |
$238,050 |
D/D |
(15,000) |
3,999 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2017-11-16 |
4 |
D |
$44.23 |
$233,932 |
D/D |
(5,289) |
60,549 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2016-01-19 |
4 |
AS |
$14.12 |
$211,800 |
D/D |
(15,000) |
3,999 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2018-02-16 |
4 |
S |
$82.94 |
$211,082 |
D/D |
(2,545) |
68,857 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2015-11-11 |
4 |
AS |
$13.52 |
$202,800 |
D/D |
(15,000) |
3,499 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2020-11-16 |
4 |
S |
$16.93 |
$202,754 |
D/D |
(11,976) |
159,757 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2021-08-16 |
4 |
S |
$13.83 |
$184,478 |
D/D |
(13,339) |
137,822 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2016-03-09 |
4 |
AS |
$11.79 |
$176,850 |
D/D |
(15,000) |
5,158 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2016-02-10 |
4 |
AS |
$11.49 |
$172,350 |
D/D |
(15,000) |
3,999 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2019-02-04 |
4 |
OE |
$10.69 |
$172,312 |
D/D |
16,119 |
184,318 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Accounting Officer |
• – – |
2015-10-06 |
4 |
AS |
$10.99 |
$164,850 |
D/D |
(15,000) |
3,499 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
